4//SEC Filing
Mast Therapeutics, Inc. 4
Accession 0001209191-14-001221
$SVRACIK 0001160308operating
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:02 PM ET
Size
10.0 KB
Accession
0001209191-14-001221
Insider Transaction Report
Form 4
Vetticaden Santosh
Chief Medical Officer & SVP
Transactions
- Award
Employee Stock Option (Right to Buy)
2014-01-02+295,100→ 295,100 totalExercise: $0.47Exp: 2024-01-02→ Common Stock (295,100 underlying)
Footnotes (1)
- [F1]This option has a January 2, 2014 vesting commencement date and vests and becomes exercisable in 48 substantially equal monthly installments over the 48-month period following the vesting commencement date, subject to the reporting person's continued service with the issuer.
Issuer
Mast Therapeutics, Inc.
CIK 0001160308
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001160308
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 6:02 PM ET
- Size
- 10.0 KB